CLINICAL OUTCOMES OF ENDOSCOPIC MICRODEBRIDER-ASSISTED ADENOTONSILLOTOMY

Adenotonsillotomy (ATT) is one of the most frequently performed surgical procedures in otorhinolaryngology. The issue of selecting the optimal ATT technique and minimizing postoperative complications and recurrence remains unresolved. To determine the effectiveness and feasibility of endoscopic microdebrider-assisted adenotonsillotomy (EMAATT) in children, a study was conducted involving 80 patients aged 3 to 18 years. Endoscopic microdebrider-assisted adenotonsillotomy was performed in all 30 patients of the main group, including 12 boys and 18 girls. The results of the study demonstrated that

EMAATT reduces the incidence of intraoperative and postoperative bleeding from 12.2 ± 0.07% in the control group to 1.3 ± 0.01% in the main group (p = 0.003) and decreases intraoperative blood loss from 166.1 ± 39.3 mL to 20.9 ± 18.9 mL (p = 0.0001). Furthermore, EMAATT significantly reduced the frequency of bleeding in patients with grade II–III hypertrophy of the pharyngeal and palatine tonsils associated with complex changes in the facial skeleton and surrounding soft tissues, malocclusion, and recurrence, from 13.5% in the control group to 0% in the main group. Ultimately, this technique represents a more conservative and function-preserving surgical approach, allowing endoscopic microdebrider-assisted adenotonsillotomy to be recommended as a method of choice.